Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours (Q34013815)

30 July 2017

1 reference

title

Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours (English)

1 reference

30 July 2017

Ghossein RA

1

1 reference

PubMed ID

10959054

30 July 2017

Bhattacharya S

series ordinal

2

1 reference

30 July 2017

1 August 2000

1 reference

European Journal of Cancer

30 July 2017

1 reference

30 July 2017

36

1 reference

30 July 2017

13 Spec No

1 reference

30 July 2017

1681-1694

1 reference

Detection of neuroblastoma cells in blood

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of micrometastases in patients with primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Use of monoclonal antibody MBr1 to detect micrometastases in bone marrow specimens of breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of micrometastatic tumor cells in bone marrow of breast carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Keratins versus epithelial membrane antigen in tumor diagnosis: an immunohistochemical comparison of five monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of circulating tumor cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

In Situ Hybridization of Prostate-Specific Antigen mRNA in Human Prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

False-positive results with PCR to detect leukaemia-specific transcript.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Illegitimate transcription: its use in the study of inherited disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Reverse transcriptase-polymerase chain reaction assays for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Real time quantitative PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

The molecular detection of circulating tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of circulating tumor cells in men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase-polymerase chain reaction assay in patients with early stage prostate carcinoma. Independence from other pretreatment characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Prostate-specific membrane antigen-derived primers in a nested reverse transcription polymerase chain reaction for detecting prostatic cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection and clearance of prostate cells subsequent to ultrasound-guided needle biopsy as determined by multiplex nested reverse transcription polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) follo

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Preoperative nested reverse transcription-polymerase chain reaction for prostate specific membrane antigen predicts biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Simultaneous detection of circulating prostate specific antigen (PSA)-expressing and prostate specific membrane antigen (PSM)-expressing cells by a multiplex reverse transcriptase polymerase chain reaction (RT-PCR) assay

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Prostate-specific membrane antigen (PSMA): current benefits and future value

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of intraoperative tumor cell dissemination in patients with breast cancer by use of reverse transcription and polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Putative markers for the detection of breast carcinoma cells in blood

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: comparison with immunocytochemistry.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein geneEGP-2

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcription-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Polymerase chain reaction for detection of melanoma in peripheral blood: too early to assess clinical value

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Hematogenous spread of malignant melanoma cells in different stages of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Reverse transcriptase-polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment, and recurrence from melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Molecular staging of malignant melanoma: correlation with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

New prognostic factors in melanoma: mRNA tumour markers.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Lung cancer metastatic cells detected in blood by reverse transcriptase-polymerase chain reaction and dot-blot analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptase-polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Identification of carcinoembryonic antigen mRNA in circulating peripheral blood of pancreatic carcinoma and gastric carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Micrometastases and survival in stage II colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of carcinoembryonic antigen messenger RNA in lymph nodes from patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection and characterization of carcinoma cells in the blood

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

Detection of circulating melanoma cells by immunomagnetic cell sorting

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900152-0

7 January 2021

10.1016/S0959-8049(00)00152-0

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10959054